您的位置: 首页 > 农业专利 > 详情页

Heterocyclic compound
专利权人:
Takeda Pharmaceutical Company Limited
发明人:
Kitamura, Shuji,Ikeda, Zenichi,Ikoma, Minoru,Watanabe, Koji,Hirose, Hideki,Yukawa, Takafumi,Morimoto, Sachie,Nishizawa, Naoki,Asami, Taiji
申请号:
AU2018257332
公开号:
AU2018257332A1
申请日:
2018.04.26
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
Provided is a compound which has calcium-sensitive receptor antagonistic activity, and which may be expected to be useful as an agent for the prevention and/or treatment of cardiac failure, pulmonary hypertension and the like, or a salt of said compound. The compound represented by formula (I) or a salt of said compound has calcium-sensitive receptor antagonistic activity, and may be expected to be useful as an agent for the prevention and/or treatment of cardiac failure, pulmonary hypertension and the like. [In the formula, each of the symbols is as described in the description.]
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充